Works matching AU Garcia-Doval, I.

Results: 54
    1
    2
    3
    4
    5

    EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 2, p. 281, doi. 10.1111/jdv.16926
    By:
    • Nast, A.;
    • Smith, C.;
    • Spuls, P.I.;
    • Avila Valle, G.;
    • Bata‐Csörgö, Z.;
    • Boonen, H.;
    • De Jong, E.;
    • Garcia‐Doval, I.;
    • Gisondi, P.;
    • Kaur‐Knudsen, D.;
    • Mahil, S.;
    • Mälkönen, T.;
    • Maul, J.T.;
    • Mburu, S.;
    • Mrowietz, U.;
    • Reich, K.;
    • Remenyik, E.;
    • Rønholt, K.M.;
    • Sator, P.G.;
    • Schmitt‐Egenolf, M.
    Publication type:
    Article
    6

    EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 11, p. 2461, doi. 10.1111/jdv.16915
    By:
    • Nast, A.;
    • Smith, C.;
    • Spuls, P.I.;
    • Avila Valle, G.;
    • Bata‐Csörgö, Z.;
    • Boonen, H.;
    • De Jong, E.;
    • Garcia‐Doval, I.;
    • Gisondi, P.;
    • Kaur‐Knudsen, D.;
    • Mahil, S.;
    • Mälkönen, T.;
    • Maul, J.T.;
    • Mburu, S.;
    • Mrowietz, U.;
    • Reich, K.;
    • Remenyik, E.;
    • Rønholt, K.M.;
    • Sator, P.G.;
    • Schmitt‐Egenolf, M.
    Publication type:
    Article
    7
    8
    9
    10
    11

    Mohs micrographic surgery in the elderly: comparison of tumours, surgery and first‐year follow‐up in patients younger and older than 80 years old in REGESMOHS.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 1, p. 108, doi. 10.1111/jdv.14586
    By:
    • on behalf of REGESMOHS (Registro Español de Cirugía de Mohs);
    • Camarero‐Mulas, C.;
    • Navarro Tejedor, R.;
    • Delgado Jiménez, Y.;
    • Barchino, L.;
    • Ciudad‐Blanco, C.;
    • Cano‐Martinez, N.;
    • Suarez Fernández, R.;
    • Toll‐Abelló, A.;
    • Artola Igarza, J. L.;
    • Allende Markixana, I.;
    • Ocerin‐Guerra, I.;
    • Alfaro Rubio, A.;
    • Hueso, L.;
    • Alonso Pacheco, M. L.;
    • Mayor Arenal, M.;
    • Vázquez‐Veiga, H.;
    • Seoane‐Pose, M. J.;
    • de la Cueva Dobao, P.;
    • Garcia‐Doval, I.
    Publication type:
    Article
    12

    Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 10, p. 1700, doi. 10.1111/jdv.14314
    By:
    • Belinchón, I.;
    • Ramos, J.M.;
    • Carretero, G.;
    • Ferrándiz, C.;
    • Rivera, R.;
    • Daudén, E.;
    • De la Cueva ‐ Dobao, P.;
    • Gómez ‐ García, F.J.;
    • Herrera ‐ Ceballos, E.;
    • Sánchez ‐ Carazo, J.L.;
    • López ‐ Estebaranz, J.L.;
    • Alsina, M.;
    • Ferrán, M.;
    • Torrado, R.;
    • Carrascosa, J.M.;
    • Llamas ‐ Velasco, M.;
    • Ortiz, P.L.;
    • García ‐ Doval, I.;
    • Descalzo, M.A.
    Publication type:
    Article
    13

    Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 6, p. 1021, doi. 10.1111/jdv.14188
    By:
    • Pérez ‐ Plaza, A.;
    • Carretero, G.;
    • Ferrandiz, C.;
    • Vanaclocha, F.;
    • Gómez ‐ García, F.J.;
    • Herrera ‐ Ceballos, E.;
    • De la Cueva ‐ Dobao, P.;
    • Belinchón, I.;
    • Sánchez ‐ Carazo, J.L.;
    • Alsina, M.;
    • López ‐ Estebaranz, J.L.;
    • Ferrán, M.;
    • Torrado, R.;
    • Carrascosa, J.M.;
    • Llamas ‐ Velasco, M.;
    • Rivera, R.;
    • Jiménez ‐ Puya, R.;
    • García ‐ Doval, I.;
    • Descalzo, M.A.;
    • Ruiz ‐ Genao, Diana
    Publication type:
    Article
    14
    15

    Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2016, v. 30, n. 11, p. 1942, doi. 10.1111/jdv.13682
    By:
    • Dávila ‐ Seijo, P.;
    • Dauden, E.;
    • Carretero, G.;
    • Ferrandiz, C.;
    • Vanaclocha, F.;
    • Gómez ‐ García, F. ‐ J.;
    • Herrera ‐ Ceballos, E.;
    • De la Cueva ‐ Dobao, P.;
    • Belinchón, I.;
    • Sánchez ‐ Carazo, J. ‐ L.;
    • Alsina, M.;
    • López ‐ Estebaranz, J. ‐ L.;
    • Ferrán, M.;
    • Torrado, R.;
    • Carrascosa, J. ‐ M.;
    • Llamas, M.;
    • Rivera, R.;
    • Jiménez ‐ Puya, R.;
    • García ‐ Doval, I.;
    • Zafrilla, Beatriz Pérez
    Publication type:
    Article
    16

    Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 5, p. 858, doi. 10.1111/jdv.12688
    By:
    • Medina, C.;
    • Carretero, G.;
    • Ferrandiz, C.;
    • Dauden, E.;
    • Vanaclocha, F.;
    • Gómez ‐ García, F.J.;
    • Herrera ‐ Ceballos, E.;
    • De la Cueva ‐ Dobao, P.;
    • Belinchón, I.;
    • Sánchez ‐ Carazo, J.L.;
    • Alsina, M.;
    • López ‐ Estebaranz, J.L.;
    • Ferrán, M.;
    • Carrascosa, J.M.;
    • Torrado, R.;
    • Argila, D.;
    • Rivera, R.;
    • Jiménez ‐ Puya, R.;
    • García ‐ Doval, I.
    Publication type:
    Article
    17

    Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 1, p. 156, doi. 10.1111/jdv.12492
    By:
    • Carretero, G.;
    • Ferrandiz, C.;
    • Dauden, E.;
    • Vanaclocha Sebastián, F.;
    • Gómez ‐ García, F.J.;
    • Herrera ‐ Ceballos, E.;
    • De la Cueva ‐ Dobao, P.;
    • Belinchón, I.;
    • Sánchez ‐ Carazo, J.L.;
    • Alsina ‐ Gibert, M.;
    • López ‐ Estebaranz, J.L.;
    • Ferrán, M.;
    • Torrado, R.;
    • Carrascosa, J.M.;
    • Carazo, C.;
    • Rivera, R.;
    • Jiménez ‐ Puya, R.;
    • García ‐ Doval, I.
    Publication type:
    Article
    18

    Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2014, v. 28, n. 7, p. 907, doi. 10.1111/jdv.12208
    By:
    • Carrascosa, J.M.;
    • Vilavella, M.;
    • Garcia ‐ Doval, I.;
    • Carretero, G.;
    • Vanaclocha, F.;
    • Daudén, E.;
    • Gómez ‐ García, F.J.;
    • Herrera ‐ Ceballos, E.;
    • De la Cueva Dobao, P.;
    • Belinchón, I.;
    • Sánchez ‐ Carazo, J.L.;
    • Alsina, M.;
    • López ‐ Estebaranz, J.L.;
    • Ferrán, M.;
    • Peral, F.;
    • Torrado, R.;
    • Rivera, R.;
    • Jiménez ‐ Puya, R.;
    • Mendiola, M.V.;
    • Ferrándiz, C.
    Publication type:
    Article
    19

    Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2013, v. 27, n. 11, p. 1366, doi. 10.1111/jdv.12011
    By:
    • Sánchez ‐ Moya, A.I.;
    • García ‐ Doval, I.;
    • Carretero, G.;
    • Sánchez ‐ Carazo, J.;
    • Ferrandiz, C.;
    • Herrera Ceballos, E.;
    • Alsina, M.;
    • Ferrán, M.;
    • López ‐ Estebaranz, J. ‐ L.;
    • Gómez ‐ García, F.;
    • De la Cueva Dobao, P.;
    • Carrascosa, J. ‐ M.;
    • Vanaclocha, F.;
    • Belinchón, I.;
    • Peral, F.;
    • DaudEN, E.
    Publication type:
    Article
    20
    21
    22
    23
    24

    Chloroquine-induced myopathy.

    Published in:
    Lupus, 2011, v. 20, n. 7, p. 773, doi. 10.1177/0961203310385553
    By:
    • Posada, C.;
    • García-Cruz, A.;
    • García-Doval, I.;
    • Millán, B. San;
    • Teijeira, S.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    特应性湿疹的治疗 (TREAT) 登记工作组:比较 Dupilumab 与其他全身药物治疗中度至重度湿疹安全性的方法

    Published in:
    British Journal of Dermatology, 2020, v. 182, n. 6, p. e199, doi. 10.1111/bjd.19078
    By:
    • Bosma, A.L.;
    • Spuls, P.I.;
    • Garcia‐Doval, I.;
    • Naldi, L.;
    • Prieto‐Merino, D.;
    • Tesch, F.;
    • Apfelbacher, C.J.;
    • Arents, B.W.M.;
    • Barbarot, S.;
    • Baselga, E.;
    • Deleuran, M.;
    • Eichenfield, L.F.;
    • Gerbens, L.A.A.;
    • Irvine, A.D.;
    • Manca, A.;
    • Mendes‐Bastos, P.;
    • Middelkamp‐Hup, M.A.;
    • Roberts, A.;
    • Seneschal, J.;
    • Svensson, Å.
    Publication type:
    Article
    31

    TREatment of ATopic eczema (TREAT) Registry Taskforce: method for comparing the safety of dupilumab with other systemic therapies for moderate‐to‐severe eczema.

    Published in:
    British Journal of Dermatology, 2020, v. 182, n. 6, p. e187, doi. 10.1111/bjd.19066
    By:
    • Bosma, A.L.;
    • Spuls, P.I.;
    • Garcia‐Doval, I.;
    • Naldi, L.;
    • Prieto‐Merino, D.;
    • Tesch, F.;
    • Apfelbacher, C.J.;
    • Arents, B.W.M.;
    • Barbarot, S.;
    • Baselga, E.;
    • Deleuran, M.;
    • Eichenfield, L.F.;
    • Gerbens, L.A.A.;
    • Irvine, A.D.;
    • Manca, A.;
    • Mendes‐Bastos, P.;
    • Middelkamp‐Hup, M.A.;
    • Roberts, A.;
    • Seneschal, J.;
    • Svensson, Å.
    Publication type:
    Article
    32

    TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

    Published in:
    British Journal of Dermatology, 2020, v. 182, n. 6, p. 1423, doi. 10.1111/bjd.18452
    By:
    • Bosma, A.L.;
    • Spuls, P.I.;
    • Garcia‐Doval, I.;
    • Naldi, L.;
    • Prieto‐Merino, D.;
    • Tesch, F.;
    • Apfelbacher, C.J.;
    • Arents, B.W.M.;
    • Barbarot, S.;
    • Baselga, E.;
    • Deleuran, M.;
    • Eichenfield, L.F.;
    • Gerbens, L.A.A.;
    • Irvine, A.D.;
    • Manca, A.;
    • Mendes‐Bastos, P.;
    • Middelkamp‐Hup, M.A.;
    • Roberts, A.;
    • Seneschal, J.;
    • Svensson, Å.
    Publication type:
    Article
    33
    34
    35
    36
    37

    银屑病的生物治疗和癌症风险.

    Published in:
    British Journal of Dermatology, 2018, v. 179, n. 4, p. e187, doi. 10.1111/bjd.17177
    By:
    • Garcia‐Doval, I.;
    • Descalzo, M.A.;
    • Mason, K.J.;
    • Cohen, A.D.;
    • Ormerod, A.D.;
    • Gómez‐García, F.J.;
    • Cazzaniga, S.;
    • Feldhamer, I.;
    • Ali, H.;
    • Herrera‐Acosta, E.;
    • Griffiths, C.E.M.;
    • Stern, R.;
    • Naldi, L.
    Publication type:
    Article
    38

    Biological therapy for psoriasis and risk of cancer.

    Published in:
    British Journal of Dermatology, 2018, v. 179, n. 4, p. e175, doi. 10.1111/bjd.17166
    By:
    • Garcia‐Doval, I.;
    • Descalzo, M.A.;
    • Mason, K.J.;
    • Cohen, A.D.;
    • Ormerod, A.D.;
    • Gómez‐García, F.J.;
    • Cazzaniga, S.;
    • Feldhamer, I.;
    • Ali, H.;
    • Herrera‐Acosta, E.;
    • Griffiths, C.E.M.;
    • Stern, R.;
    • Naldi, L.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46

    Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

    Published in:
    British Journal of Dermatology, 2017, v. 176, n. 3, p. 643, doi. 10.1111/bjd.14776
    By:
    • García ‐ Doval, I.;
    • Hernández, M.V.;
    • Vanaclocha, F.;
    • Sellas, A.;
    • Cueva, P.;
    • Montero, D.;
    • Rodríguez, Basilio;
    • Barceló, Mireia;
    • Farietta, Sandra;
    • Montoro, María;
    • González, Ainhoa;
    • Herráez, Elena;
    • Ruíz ‐ Montesino, Mª Dolores;
    • Vargas, Carmen;
    • Pérez ‐ Pampín, Eva;
    • Ortiz, Ana Mª;
    • Tomero, Eva;
    • Sifuentes, Alberto;
    • Antón, Fred;
    • Zea, Antonio
    Publication type:
    Article
    47
    48

    Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership.

    Published in:
    British Journal of Dermatology, 2015, v. 173, n. 5, p. 1280, doi. 10.1111/bjd.13914
    By:
    • Hernández ‐ Martín, A.;
    • Dávila ‐ Seijo, P.;
    • Lucas, R.;
    • Baselga, E.;
    • Redondo, P.;
    • Martín ‐ Santiago, A.;
    • Azaña ‐ Defez, J.M.;
    • González ‐ Viejo, I.;
    • Jiménez ‐ Ferreres, L.;
    • González ‐ Enseñat, M.A.;
    • Arroyo ‐ Manzanal, M.I.;
    • Soria, J.M.;
    • Garcia ‐ Doval, I.
    Publication type:
    Article
    49
    50